EaseVRx

A woman using an AppliedVR headset at home
AppliedVR’s EaseVRx scores FDA De Novo clearance for treating chronic lower back pain
By Emily Olsen | 12:43 pm | November 17, 2021
The news comes about a week after AppliedVR announced it raised $36 million in Series B funding.
FDA slates VR for lower back pain and fibromyalgia for expedited review
By Laura Lovett | 01:10 pm | October 21, 2020
AppliedVR's EaseVRx landed an FDA Breakthrough Device designation for its tool that combines VR and cognitive behavioral therapy.